CBS 2019
CBSMD教育中心
中 文

双重抗血小板治疗持续时间

Abstract

Recommended Article

Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis Patient Selection and Clinical Outcomes in the STOPDAPT-2 Trial: An All-Comer Single-Center Registry During the Enrollment Period of the STOPDAPT-2 Randomized Controlled Trial Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial A randomized comparison of Coronary Stents according to Short or Prolonged durations of Dual Antiplatelet Therapy in patients with Acute Coronary Syndromes: a pre-specified analysis of the SMART-DATE trial Genotyping to Guide Clopidogrel Treatment: An In-Depth Analysis of the TAILOR-PCI Trial Aspirin-Free Prasugrel Monotherapy Following Coronary Artery Stenting in Patients With Stable CAD: The ASET Pilot Study

Review Article2018 Oct;8(5):630-646.

JOURNAL:Cardiovasc Diagn Ther. Article Link

The optimal duration of dual antiplatelet therapy after coronary stent implantation: to go too far is as bad as to fall short

Costa F, Valgimigli M. Keywords: DAPT duration; Dual antiplatelet therapy (DAPT); PRECISE-DAPT; bleeding; coronary stenting

FULL TEXT PDF